Quick Answer
Legend Biotech Corp reported R&D Expense of $414.70 million for fiscal year 2025.
Legend Biotech Corp R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $414.70M | +0.3% |
| 2024 | $413.50M | +8.2% |
| 2023 | $382.20M | +13.9% |
| 2022 | $335.65M | +7.1% |
| 2021 | $313.35M | +35.0% |
| 2020 | $232.16M | +43.4% |
| 2019 | $161.94M | +167.1% |
| 2018 | $60.64M | — |
- Legend Biotech Corp showed an increase of +0.3% in R&D Expense compared to the prior fiscal year.
- Over the 2018–2025 period, Legend Biotech Corp’s r&d expense has grown by 583.9% (from $60.64 million to $414.70 million).
- The most recent figure is from Legend Biotech Corp’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 10, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: